Preventive strategy for post-ERCP pancreatitis.
10.11817/j.issn.1672-7347.2019.02.014
- Author:
Baohong GU
1
;
Xuemei LI
1
;
Jike HU
1
;
Fan ZHANG
1
;
Juanjuan LU
2
;
Hao CHEN
2
Author Information
1. Second Clinical Medical College, Lanzhou University, Lanzhou 730030, China.
2. Department of Tumor Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
- Publication Type:Journal Article
- MeSH:
Anti-Inflammatory Agents, Non-Steroidal;
Cholangiopancreatography, Endoscopic Retrograde;
adverse effects;
Humans;
Incidence;
Pancreatitis;
etiology;
Risk Factors;
Stents
- From:
Journal of Central South University(Medical Sciences)
2019;44(2):209-215
- CountryChina
- Language:Chinese
-
Abstract:
Endoscopic retrograde cholangiopancreatography (ERCP) is an irreplaceable measure with minimally invasive diagnosis and treatment of endoscopy for biliary and pancreatic diseases, but the related complications associated with ERCP are the highest among the endoscopic procedures. Post-ERCP pancreatitis (PEP) is one of the most common complications with life-threatening in severe cases. Early active prevention can effectively reduce the incidence of post-ERCP pancreatitis. At present, measures including preoperative rectal non-steroidal anti-inflammatory drugs and prophylactic pancreatic stent placement, have definite effective strategy in clinic. Aggressive hydration with lactated Ringer's solution is also a safe and effective way to prevent PEP.
